What this is
Single filing record
This page shows the rows from one Form 4 filing as reported to the SEC.
Blue Collar Picks
Big buy
$16.2M open-market purchase by Novo Holdings A/S, 10% Owner at MapLight Therapeutics,Inc., filed October 30, 2025. Learn more
What this is
This page shows the rows from one Form 4 filing as reported to the SEC.
Why it matters
The original SEC document is the source record. Always verify before drawing conclusions.
How to read it
Insider activity carries more weight from senior officers, large dollar values, and clustered timing.
Stacked feeds
Novo Holdings A/S · 10% Owner at MapLight Therapeutics,Inc.
Novo Holdings A/S bought $16.2M of MPLT (MapLight Therapeutics,Inc.).
Insider purchase
Novo Holdings A/S, a 10% beneficial owner, reported a $16.2M open-market purchase equal to 3.2% of MPLT's market cap.
Novo Holdings A/S (10% Owner) bought 952,941 shares of MPLT, MapLight Therapeutics,Inc., Healthcare ($506.4M market cap), at $17.00 per share on October 28, 2025 for a total of $16.2M (3.2% of the market cap).
Novo Holdings A/S
10% Owner
Permalink https://bluecollarpicks.com/insider-trading/MPLT/buy/68911
Market context
Last enriched September 20, 2026 at 5:04 AM EDT.
Filings
Latest visible filing loading.
Public Form 4 filings, normalized for cleaner scanning. What do these codes mean?
| Ticker | Type & Role | Value | |
|---|---|---|---|
| This filing | Big Buy 10% Owner | $16.2M | |
| $192.7K | |||
Buy Director | $148.7K | ||
Sell Officer | $80.6K | ||
Sell Officer | $258.7K | ||
Grant Director | $0 | ||
Grant Director | $0 | ||
Grant Director | $0 | ||
Grant Director | $0 | ||
Grant Director | $0 | ||
Sell CEO | $3.2M | ||
Sell CFO | $131.4K | ||
Sell Officer | $229K | ||
Sell Officer | $88.2K | ||
Sell Officer | $95.5K | ||
Sell Officer | $2K | ||
Sell Officer | $6.2K | ||
Sell Officer | $41K | ||
Sell CFO | $783 | ||
Sell CFO | $2.4K | ||
Sell CFO | $75.4K | ||
Sell Officer | $18.5K | ||
Sell Officer | $57.6K | ||
Sell Officer | $46.4K | ||
Sell Officer | $7.8K | ||
Sell Officer | $24.2K | ||
Sell Officer | $54.9K | ||
Sell CEO | $66.9K | ||
Sell CEO | $208.2K | ||
Sell CEO | $246K | ||
Sell Director | $231.2K | ||
Sell Director | $13.4K | ||
Sell Director | $9.1K | ||
Sell Director | $198.4K | ||
Sell Director | $39.6K | ||
Buy Director | $177.2K | ||
Buy Director | $77.7K | ||
Buy Director | $186.3K | ||
Sell Director | $220.6K | ||
Buy Director | $252.7K | ||
Sell Director | $4.3K | ||
Sell Director | $120K | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Grant CFO | $0 | ||
Grant CFO | $0 | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Selected filing
Select a row to inspect the filing.
Cluster detail
Ticker context
Recent insider activity for this company.
Insider detail
Recent transactions grouped by reporting owner.
Filters
Weekly recap
Start with the free weekly recap. Upgrade later if you want the paid daily brief.
Free weekly recap. No login required. Unsubscribe any time.
Method Public Form 4 filings, normalized for cleaner scanning. Filtered rows stay available in All Form 4 Filings and ticker history. Which view should I use? →
Paid research tools
Join the waitlist for founding-member access to CSV exports, saved screens, and premium download tools when they open.